持续皮下胰岛素输注(CSⅡ),又称为胰岛素注射泵,CSⅡ的概念最早在1960年提出的,70年代后期进入临床,CSⅡ与血糖监测的结合体现了真正意义上的“胰岛素强化治疗”。从严格意义上说,CSⅡ是目前最符合生理状态的胰岛素输注方式,它可以使血糖控制在正常并保持稳定,减少严重低血糖的危险,对延迟和减少并发症的发生非常有效。[1] Continuous subcutaneous insulin infusion (CS Ⅱ), also known as insulin pump, the concept of CS Ⅱ was first proposed in 1960, entered the clinic in the late 1970s, CS Ⅱ and the combination of blood glucose monitoring reflects the true sense of the “insulin intensive treatment.” Strictly speaking, CSII is the most physiologically appropriate insulin infusion method currently available. It keeps blood sugar normal and stable, reduces the risk of severe hypoglycaemia and is very effective in delaying and reducing the incidence of complications. [1]